Literature DB >> 22222191

Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos.

Juan A Garcia-Velasco1.   

Abstract

Agonist triggering combined with oocyte vitrification and ET in a subsequent natural cycle avoids ovarian hyperstimulation syndrome in patients at risk and shows excellent cycle outcome.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22222191     DOI： 10.1016/j.fertnstert.2011.12.010

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  10 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  GnRH Antagonist Cetrorelix Administration Before hCG for Protection of Ovarian Hyperstimulation Syndrome.

Authors:  Sherif A Hebisha; Banan A Aboelazm; H N Sallam
Journal:  J Obstet Gynaecol India       Date:  2016-11-29

3.  NMR metabolomics study of follicular fluid in women with cancer resorting to fertility preservation.

Authors:  Maria Antonietta Castiglione Morelli; Assunta Iuliano; Sergio Crescenzo Antonio Schettini; Donatina Petruzzi; Angela Ferri; Paola Colucci; Licia Viggiani; Flavia Cuviello; Angela Ostuni
Journal:  J Assist Reprod Genet       Date:  2018-08-01       Impact factor: 3.412

4.  Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition.

Authors:  Samuel Santos-Ribeiro; Nikolaos P Polyzos; Katrien Stouffs; Michel De Vos; Sara Seneca; Herman Tournaye; Christophe Blockeel
Journal:  J Assist Reprod Genet       Date:  2015-05-17       Impact factor: 3.412

5.  Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer.

Authors:  Danilo Cimadomo; Alberto Vaiarelli; Cecilia Petriglia; Gemma Fabozzi; Susanna Ferrero; Mauro Schimberni; Cindy Argento; Silvia Colamaria; Maddalena Giuliani; Nicolò Ubaldi; Laura Rienzi; Filippo Maria Ubaldi
Journal:  J Assist Reprod Genet       Date:  2021-03-04       Impact factor: 3.357

Review 6.  GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article.

Authors:  Ashraf Alyasin; Shayesteh Mehdinejadiani; Marzieh Ghasemi
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-09

7.  Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders.

Authors:  Meric Karacan; Erkan Erdem; Akin Usta; Ayse Arvas; Ziya Cebi; Teksen Camlibel
Journal:  Saudi Med J       Date:  2017-06       Impact factor: 1.484

Review 8.  Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.

Authors:  Juan Carlos Castillo; Thor Haahr; María Martínez-Moya; Peter Humaidan
Journal:  Ups J Med Sci       Date:  2020-05-04       Impact factor: 2.384

9.  Spontaneous ovarian hyperstimulation syndrome following a thawed embryo transfer cycle.

Authors:  Mi Kyoung Kim; Hyung Jae Won; Sung Han Shim; Dong Hyun Cha; Tae Ki Yoon
Journal:  Clin Exp Reprod Med       Date:  2014-09-30

10.  HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes.

Authors:  Krishna Deepika; Rathore Suvarna; Maria Sumi; Dhoble Snehal; Vohra Arveen; Kamath Anuja; Pranesh Gautham; Rao Kamini
Journal:  JBRA Assist Reprod       Date:  2021-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.